Fundz

Dia Medica Therapeutics reported raising $30.1 Million in an initial SEC Form D filing, from an offering of $30.1 Million

PUBLIC · DMACJul 25, 2025

Amount Raised

$30.1 Million

$30.1 Million sold, per SEC Form D (first sale Jul 23, 2025)

Round Type

Venture

MinneapolisBiotechnologyHealth CareTherapeuticsBiopharma

Who to call at DiaMedica Therapeutics, and when

A new round usually means DiaMedica Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DiaMedica Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DiaMedica Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DiaMedica Therapeutics

Location

301 CARLSON PARKWAY

Minneapolis, Minnesota, United States

About

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), is a clinical-stage biopharmaceutical company that is focused on developing novel treatments where there is significant unmet clinical need or where no current therapies are available, with the focus on acute ischemic stroke and preeclampsia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DiaMedica Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts9 people are listed at DiaMedica Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for DiaMedica Therapeutics's next move

See what Strategic adds

DiaMedica Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.